Skip to main content

Featured

Your daily horoscope: May 9, 2025

  IF TODAY IS YOUR BIRTHDAY A change of direction is a must this year as you have reached the end of your current journey and need a new challenge. Make a break with the past and make it one that cannot be reversed. Move forward fast and don’t look back. ARIES (March 21 - April 20): Someone you meet on your travels will catch your eye and maybe your heart as well. If it’s true that opposites attract you could find yourself getting close to someone whose charms are very different to your own – and remarkably the relationship will work. TAURUS (April 21 - May 21): Someone you think of as a friend will say something today that annoys you intensely. It may be the case though that they can see things that you cannot, so be open to what they tell you. They could be doing you a very big favor. GEMINI (May 22 - June 21): If you listen too much to other people’s advice today you could end up facing in several directions at once and ultimately getting nowhere. Pay attention to what friends a...

article

Controversial Turkish Import Endangers Newborns in Alberta, Documents Reveal

 

Recent documents have raised alarming concerns over Alberta’s emergency importation of children’s pain medication from Turkey. Produced by Atabay Pharmaceuticals and sold under the brand name Parol Suspension, the drug is marketed at a concentration of 24 mg/ml—significantly lower than the 32 mg/ml concentration found in the standard, Canadian-authorized formulation.

Health experts and opposition critics warn that this altered concentration poses a twofold risk. First, the discrepancy could lead to dosing errors if parents and caregivers, accustomed to the standard formulation, misjudge the correct volume needed. Second, there are fears that the lower concentration may lead to the clogging of hospital feeding tubes—a critical concern for vulnerable newborns.

Alberta Blue Cross has informed pharmacists that Parol must be dispensed with enhanced caution, requiring additional education on its proper use. Critics argue that the rushed procurement—amounting to approximately $80 million—exemplifies a misstep in prioritizing political expedience over stringent safety protocols. With traditional supplies of children’s pain medications already in short supply, many worry that this controversial alternative might jeopardize the health of Alberta’s youngest patients.

Further review and tighter regulatory oversight are now being called for, as stakeholders demand that the province safeguard the well-being of newborns and ensure that emergency measures do not compromise pediatric care.

Comments

Popular Posts